MicroFLOQ® Direct: A Helpful Tool for the Coronavirus SARS-Cov-2 Rapid Detection without RNA Purification
International Journal of Applied Biology and Pharmaceutical Technology · 2022
DOI: 10.26502/ijabpt.202115 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Applied Biology and Pharmaceutical Technology, 2022. Verfasst von Mathilde Recipon und 13 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
In the context of SARS-Cov-2 virus disease (COVID-19) pandemic, molecular diagnostic tools were rapidly developed as there are fundamental for a rapid detection of infected people. In this context, and in order to optimize the manipulations and reduce the time to get results, we report the successful use of a sampling tool for COVID-19 diagnosis named microFLOQ® Direct (MFD). Hundred upper respiratory specimens sampled from patients with potential COVID-19 were evaluated using MFD, and results were compared to the results obtained by standard sampling procedure using dry swabs and physiologic serum as the transport medium. MFD results compared to results issued from the classic RNA purification and amplification steps from transport medium showed that MFD can be directly used for RT-PCR analysis without the preliminary inactivation and extraction steps. So, MFD could limit handling errors compared to the different treatment steps with dry swabs and transport medium. It therefore limits the risk of contamination, simplify the analytical process and enables to get results in less than 2 hours. We also show that the MFD kit is operational as a screening tool in the field of molecular detection of viral and bacterial diseases during an outbreak and then it can be used for public health or agro-veterinary purposes.
Zitieren
APA
Recipon, M., Pussiau, A., Follot, S., Latifa, N., Herrmann, J., Rottman, M., Gallet, O., Kellouche, S., Leroy-Dudal, J., Pierrini, G., Marescal, F., Touron, P., Hubac, S., & Siatka, C. (2022). MicroFLOQ® Direct: A Helpful Tool for the Coronavirus SARS-Cov-2 Rapid Detection without RNA Purification. International Journal of Applied Biology and Pharmaceutical Technology. https://doi.org/10.26502/ijabpt.202115
Vancouver
Recipon M, Pussiau A, Follot S, Latifa N, Herrmann J, Rottman M, et al. MicroFLOQ® Direct: A Helpful Tool for the Coronavirus SARS-Cov-2 Rapid Detection without RNA Purification. International Journal of Applied Biology and Pharmaceutical Technology. 2022. doi:10.26502/ijabpt.202115
BibTeX
@article{Recipon2022,
author = {Recipon, Mathilde and Pussiau, Amaury and Follot, Sébastien and Latifa, Noussair and Herrmann, Jean-Louis and Rottman, Martin and Gallet, Olivier and Kellouche, Sabrina and Leroy-Dudal, Johanne and Pierrini, Georges and Marescal, Franck and Touron, Patrick and Hubac, Sylvain and Siatka, Christian},
title = {MicroFLOQ® Direct: A Helpful Tool for the Coronavirus SARS-Cov-2 Rapid Detection without RNA Purification},
journal = {International Journal of Applied Biology and Pharmaceutical Technology},
year = {2022},
doi = {10.26502/ijabpt.202115}
}
EUVIMED